The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of CD20 expression loss as a mechanism of resistance to mosunetuzumab in patients with relapsed/refractory B-cell non-Hodgkin lymphomas.
 
Stephen J. Schuster
Consulting or Advisory Role - Acerta Pharma/AstraZeneca; BeiGene; Celgene; Genentech/Roche; Incyte; Janssen; Legend Biotech; Loxo; MorphoSys; MustangBio; Nordic Nanovector; Novartis; Regeneron
Research Funding - Abbvie (Inst); Adaptive Biotechnologies (Inst); Celgene (Inst); DTRM (Inst); Genentech/Roche (Inst); Incyte (Inst); Juno Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patent Combination Therapies of CAR and PD-1 Inhibitors (via University of Pennsylvania with royalties to Novartis)
 
Ling-Yuh Huw
Stock and Other Ownership Interests - F. Hoffmann LaRoche
 
Christopher R. Bolen
Employment - Genentech
Stock and Other Ownership Interests - F. Hoffmann LaRoche
Patents, Royalties, Other Intellectual Property - Genentech
 
Sarit E. Assouline
Honoraria - Abbvie; AstraZeneca; BMS; Novartis Canada Pharmaceuticals Inc; Pfizer; Roche/Genentech
Consulting or Advisory Role - Beigene; Roche/Genentech
Research Funding - Astex Pharmaceuticals (Inst); BeiGene (Inst); Novartis (Inst); Roche Canada (Inst); Takeda (Inst)
 
Nancy L. Bartlett
Consulting or Advisory Role - Acerta Pharma; ADC Therapeutics; BTG; Roche/Genentech; Seagen
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
L Elizabeth Budde
Consulting or Advisory Role - BeiGene; Kite/Gilead; Novartis; Roche/Genentech
Research Funding - Amgen; AstraZeneca; Merck; MustangBio
Patents, Royalties, Other Intellectual Property - CCR4 CAR T cells for treatment of patients with CCR4 positive cancer.; CD33CAR for treatment of patients with CD33+ acute myeloid leukemia.
Travel, Accommodations, Expenses - Kite/Gilead; Roche/Genentech
 
Matthew J. Matasar
Stock and Other Ownership Interests - Merck
Honoraria - Bayer; Epizyme; Genentech; GlaxoSmithKline; Immunovaccine; Janssen; Pharmacyclics; Roche; Seagen; Takeda
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Epizyme; Genentech; Juno Therapeutics; Merck; Roche; Rocket Medical; Seagen; Takeda; Teva
Research Funding - Bayer; Genentech; GlaxoSmithKline; IGM Biosciences; IGM Biosciences; Immunovaccine; Janssen; Pharmacyclics; Roche; Rocket Medical; Seagen
Travel, Accommodations, Expenses - Bayer; Genentech; Roche; Seagen
 
Hartmut Koeppen
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Emily C. Piccione
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Deanna Wilson
Employment - Genentech
Stock and Other Ownership Interests - F. Hoffmann LaRoche
 
Michael C. Wei
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Shen Yin
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
 
Elicia M. Penuel
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche